Skip to main content
OpenTrials
Completed

NCT Number: NCT07389122

Adherence and Tolerability of Four Very Low-Calorie Ketogenic Diet Approaches in Adults With Obesity or Complicated Overweight

This study, called KOBE Study, looks at how well different very low-calorie ketogenic diets (VLCKD) are followed and tolerated by adults with obesity or complicated overweight in routine clinical practice.

Ketogenic diets are medical nutrition therapies that greatly reduce carbohydrates and calories to promote weight loss and improve metabolic health. Several VLCKD approaches are used in clinical care, but they differ in the type of protein sources used (natural foods versus meal replacements or supplements). At present, there is limited evidence comparing these approaches in terms of adherence, side effects, satisfaction, and dropout rates.

The KOBE Study is a single-center, prospective, observational study conducted during standard clinical care at a hospital nutrition clinic. Participants choose one of four VLCKD protocols based on personal preference:

* diets using only natural protein foods, * natural proteins plus one protein supplement, * natural proteins plus two meal replacements, * or diets based entirely on meal replacements.

All participants follow the same structured program lasting about 26 weeks (longer for individuals with severe obesity), consisting of:

1. an initial ketogenic phase, 2. a gradual reintroduction of carbohydrates, 3. a maintenance phase based on a low-glycemic index Mediterranean-style diet. Throughout the study, patients undergo routine clinical visits and assessments, including measurements of body weight, body composition, blood tests, liver imaging, and questionnaires on hunger, bowel habits, quality of life, and satisfaction with the diet. No additional tests beyond standard care are required.

The main goal of the study is to compare the different ketogenic protocols in terms of:

* how well patients can follow them, * how well they are tolerated, * the occurrence of side effects, * and overall satisfaction. Secondary objectives include evaluating changes in body composition, metabolic parameters, and liver health.

The results of this study aim to help patients and healthcare professionals make more informed, evidence-based decisions when choosing among different ketogenic diet options for weight management and metabolic disease.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Obesity with or without comorbidities (BMI ≥ 30 kg/m²) OR
  • Overweight with comorbidity of MASLD (BMI 25.0-29.9 kg/m²) PLUS
  • Previous unsuccessful attempt at a prescribed hypocaloric diet

Exclusion criteria

  • Age < 18 years
  • Pregnancy
  • Breastfeeding
  • Moderate or severe kidney failure
  • Cardiovascular diseases: heart failure (NYHA III-IV), unstable angina, acute coronary syndrome or stroke within the past 12 months, paroxysmal atrial fibrillation, any type of atrioventricular block, left bundle branch block
  • Liver diseases: Child-Pugh C, elevated transaminases with AST or ALT ≥ 5 times the upper limit of normal, INR ≥ 1.5, total bilirubin ≥ 2 mg/dL
  • Diabetes: type 1 diabetes mellitus, type 2 diabetes mellitus with insufficient pancreatic endocrine reserve (C-peptide < 0.8 ng/mL), type 2 diabetes mellitus on multiple daily insulin injections
  • Last attempt of VLCKD outside the research protocol within the past 12 months
  • Eating disorders: anorexia nervosa, bulimia nervosa, binge eating disorder
  • Psychiatric comorbidities, alcohol or substance dependence
  • Frail elderly patients

Treatment and study plan

Primary outcomes

  1. Adherence, collateral effects, drop-out, dietetic compliance

    Time frame: Until the end of the study

    The primary objective of the study is to evaluate, within routine clinical practice and by comparing four distinct VLCKD protocols, the therapeutic response of patients in terms of:

    (i) adherence (compliance), (ii) occurrence of adverse events, (iii) drop-out rate, and (iv) diet satisfaction.

    The four ketogenic protocols routinely used in patients undergoing VLCKD each consist of three phases; only the first phase differs among protocols, based on patients' personal preferences.

Secondary outcomes

  1. Anthropometric Measures, Body Composition, Laboratory Parameters, and Imaging Evaluations

    Time frame: Until the end of the study

    The secondary objectives are to evaluate the effects of the different VLCKD protocol arms on the trends of parameters collected during routine clinical practice, including:

    (i) first- and second-level anthropometric measurements (body weight, Body Mass Index (BMI), and circumferences); (ii) body composition; (iii) biochemical laboratory tests according to the Società italiana di Endocrinologia (SIE) Consensus Statement, with particular attention to serum creatinine levels.

    (iv) upper abdominal ultrasound and hepatic-splenic transient elastography assessed using the FibroScan technique.

Sponsors and collaborators

Lead sponsor

University of Bologna

Other

Collaborators

  • Malpighi Hospital, Bologna, Italy

Registry information

Official study title

KOBE Study: Adherence to and Tolerability of Different Very-low-calorie Ketogenic Protocols in Patients With Obesity and Complicated Overweight.

Acronym: KOBE

Important dates

Study start
2021
Primary completion
2024
Study completion
2025
First posted
Feb 5, 2026
Registry last updated
May 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.